Trump Pledges to Protect Crypto Industry and Ensure Prediction Markets Thrive Report Reveals Nifty 50s LongTerm Track Record Offers Reassurance to Foreign Investors Amid Market Headwinds US Stock Market Holidays Are SP 500 Nasdaq Closed for Trading on Memorial Day American Consumer Pessimism Persists as Inflation Geopolitical Risks and Trade Policies Weigh on Sentiment Gilead Sciences Completes 315B Acquisition of Tubulis to Strengthen Oncology Pipeline Wall Street Ends Mixed as Oil Slides on Iran Deal Hopes Micron Gains 56 GlobalFoundries Drops 9 Bunge Limited Q1 2026 Earnings Massive EPS Beat Drives Modest Stock Uptick Legato Merger Corp III LEGT Q1 2026 Earnings Positive EPS Reported Amid PreMerger Quiet Period Veris Residential Inc VRE Q4 2025 Earnings Surprise EPS Beat Amid Subdued Market Sentiment Blue Owl Capital Corporation OBDC Q1 2026 Earnings EPS Misses Estimates but Stock Posts Modest Gain FTRE Q1 2026 Earnings Earnings Beat Expectations with 241 Surprise CLDT Q1 2026 Earnings EPS Surpasses Expectations Narrowing Loss Mohawk Industries MHK Gains Nearly 2 Key Levels and Market Dynamics Amphastar Pharmaceuticals AMPH Gains 138 as Stock Consolidates Near Key Resistance Psyence Biomedical Ltd Warrant PBMWW Slides 894 as Stock Hovers at 003 TWFG Inc TWFG Shares Rebound to 1934 as Bulls Test Key Resistance Xos Inc XOS Edges Higher but Resistance Caps NearTerm Gains OraSure Technologies OSUR Surges 9 Key Levels in Focus After Breakout Move Tejon Ranch Co TRC Faces Resistance Near 20 as Shares Slip Slightly National Bank Holdings Corporation NBHC Edges Higher Amid Stable Trading SIBONE Inc SIBN Edges Lower Amid Consolidation Near Key Support Levels Wolfspeed Inc WOLF Gains 283 as Shares Approach Key Resistance Level Wintergreen Acquisition Corp Rights WTGUR Hold Steady at 010 Trading at Support Amid Thin Activity Trumps Very Disloyal Jab Texas Senator John Cornyn Faces Political Battle Amid 109 Million Ad Spending MPT Q1 2026 Earnings EPS Surges Past Estimates With 65 Beat Stock Slides Slightly Black Diamond Therapeutics BDTX Shares Tumble Nearly 35 on Clinical Setback